News und Analysen

Shares of Neumora Therapeutics (NASDAQ: NMRA) were down more than 32% for the week as of Thursday's market close, according to data provided by S&P Global Market Intelligence. The clinical-stage bio

Shares of Splunk (NASDAQ: SPLK) were up 21.3% as of 1:10 p.m. ET Thursday after the data analytics and observability specialist agreed to be acquired by Cisco Systems (NASDAQ: CSCO). 

More

Shares of Broadcom (NASDAQ: AVGO) were down 2.85% at 10:38 a.m. ET on Thursday. The major market indexes were also down today, but the stock's slide followed a report that Google parent Alphabet was

Ever since the groundbreaking release of ChatGPT, artificial intelligence (AI) has been talked about nonstop in investing circles. ChatGPT is the large language model (LLM) generative AI brought to

Dividends are great. They're a reliable source of passive income for retirees (and others) or can help boost long-term returns for investors who choose to reinvest them. But what happens when a

Stock markets continued to react Thursday morning to the latest news from the Federal Reserve the previous day, and investors didn't seem to feel comfortable with the likely future direction of

Given the current uncertain macroeconomic environment featuring high interest rates and inflationary pressures, investors might expect Apple's (NASDAQ: AAPL) latest iPhone launch to fall flat. But

For nearly every smartphone that ships, Arm Holdings (NASDAQ: ARM) gets a small piece of the sale. The same is true for a big chunk of the consumer electronics market. ARM estimates that the value

Moderna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had a lot to say. Today, everyone knows the company for its blockbuster COVID-19 vaccine -- it's only

Tech giant Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) dominates the search market with its Google search engine and is a powerhouse in streaming video with YouTube. In addition, its cloud division has

While interest in the metaverse cooled down substantially in the past couple of years, I don't think investors should completely ignore this potentially game-changing technology. There are places to

Though some parts of the market are expensive right now, others are full of opportunities. So if you've got $1,000 (or any amount of money sitting around), some great stocks are available to

Down 46% year to date, electric truck maker Nikola (NASDAQ: NKLA) has missed the market rally that boosted electic vehicle peer Tesla (up 153% in the same period). This comes as the smaller company

A look at last year's stock-split companies is kind of like taking a stroll along Hollywood's Walk of Fame. It's star-studded, featuring the industry's biggest names. Amazon (NASDAQ: AMZN), Tesla

Adding to its long history of consistent dividend growth, software-giant Microsoft (NASDAQ: MSFT) announced another dividend increase this week. Starting in December, the tech-company's quarterly

Fool.com contributor Parkev Tatevosian evaluates Fortinet (NASDAQ: FTNT) stock to answer if the stock is a bargain at current prices.

*Stock prices used were the afternoon prices of Sept. 18, 2023

In today's video, I discuss Intel (NASDAQ: INTC) and why the stock price is down after the company announced numerous technological advancements. Check out the short video to learn more, consider

Shares of semiconductor giant Intel (NASDAQ: INTC) were down by 2.2% as of 1 p.m. ET Wednesday after an executive spooked investors with remarks he made at its Innovation Conference Tuesday

As the world's most valuable company with a market cap of $2.7 trillion, Apple (NASDAQ: AAPL) has a long history of offering investors consistent gains. The company has achieved record highs and has

Adobe (NASDAQ: ADBE) stock has been on fire in 2023 with an impressive year-to-date gain of 59% as of this writing. This has been fueled primarily by the company's moves to capitalize on the growing

Regeneron Pharmaceuticals (NASDAQ: REGN) has made for a fantastic growth story over the years. From just over $2 billion in revenue in 2013, the company's top line rose to more than $12 billion last

For biotechs, having the right allies can be the difference between struggling along and soaring. On that note, on August 29 Ginkgo Bioworks (NYSE: DNA) announced that it is joining forces with

Growth investing is hot again. Investors who took a break last year and leaned toward safer stocks in a volatile economy are now more confident in the market and are back to putting their money in

In today's video, I discuss Intel (NASDAQ: INTC) and recent updates about its CPU offerings for the server and consumer market. Check out the short video to learn more, consider subscribing, and